Skip to main content
SpringerLink
Log in

Comparison of the protective efficacy between intratympanic dexamethasone and resveratrol treatments against cisplatin-induced ototoxicity: an experimental study

  • Otology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Purpose

The main aim of this study was to compare the efficacy of intratympanic administration of dexamethasone and resveratrol in preventing cisplatin ototoxicity by measuring acoustic brainstem response (ABR) and distortion product otoacoustic emission (DPOAE).

Methods

Forty rats (80 ears) were divided into five groups. Cisplatin was administered intraperitoneally to the first group (n = 8). Group 2 (n = 8) received cisplatin after resveratrol had been administered intratympanically. Group 3 (n = 8) received cisplatin after dexamethasone had been administered intratympanically. Group 4 (n = 8) received cisplatin after sodium chloride (NaCl) had been given intratympanically. Group 5 (n = 8) received cisplatin after dimethylsulfoxide (DMSO) had been given intratympanically. ABR and DPOAE tests were performed on all groups before and 72 h after the procedure.

Results

ABR threshold values in rats that received dexamethasone and resveratrol were found to be less affected than those observed in the other post-cisplatin groups. ABR-IV and ABR-I–IV interval values were significantly reduced in rats that had been given dexamethasone and resveratrol compared to the other groups. After cisplatin treatment, otoacoustic emission (OAE) amplitudes were significantly decreased in Groups 1, 4, and 5 for all frequencies, while OAE values were sustained in the resveratrol and dexamethasone groups (Groups 2 and 3). At OAE frequency 5652, dexamethasone was more significantly associated with protective than resveratrol was, while no significant difference was found between the two groups at other OAE frequencies.

Conclusion

In conclusion, intratympanic dexamethasone and intratympanic resveratrol treatments may provide a significant protection against cisplatin-induced ototoxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ganesan P, Schmiedge J, Manchaiah V, Swapna S, Dhandayutham S, Kothandaraman PP (2018) Ototoxicity: a challenge in diagnosis and treatment. J Audiol Otol 22(2):59–68

    Article  Google Scholar 

  2. Campbell KCM, Le Prell CG (2018) Drug-induced ototoxicity: diagnosis and monitoring. Drug Saf 41(5):451–464

    Article  CAS  Google Scholar 

  3. Liu W, Staecker H, Stupak H, Malgrange B, Lefebvre P, Van De Water TR (1998) Caspase inhibitors prevent cisplatin-induced apoptosis of auditory sensory cells. NeuroReport 9:2609–2614

    Article  CAS  Google Scholar 

  4. McKeage MJ (1995) Comparative adverse effect profiles of platinum drugs. Drug Saf 13:228–244

    Article  CAS  Google Scholar 

  5. Liang F, Schulte BA, Qu C, Hu W, Shen Z (2005) Inhibition of the calcium and voltage-dependent big conductance potassium channel ameliorates cisplatin-induced apoptosis in spiral ligament fibrocytes of the cochlea. Neuroscience 135:263–271

    Article  CAS  Google Scholar 

  6. Doyle KJ, Bauch C, Battista R et al (2004) Intratympanic steroid treatment: a review. Otol Neurotol 25:1034–1039

    Article  Google Scholar 

  7. Simşek G, Tokgoz SA, Vuralkan E, Caliskan M, Besalti O, Akin I (2013) Protective effects of resveratrol on cisplatin-dependent inner-ear damage in rats. Eur Arch Otorhinolaryngol 270(6):1789–1793

    Article  Google Scholar 

  8. Yumusakhuylu AC, Yazici M, Sari M, Binnetoglu A, Kosemihal E et al (2012) Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs. Int J Pediatr Otorhinolaryngol 76(3):404–408

    Article  Google Scholar 

  9. Lee SH, Kim HS, An YS, Chang J, Choi J, Im GJ (2015) Protective effect of resveratrol against cisplatin-induced ototoxicity in HEI-OC1 auditory cells. Int J Pediatr Otorhinolaryngol 79(1):58–62

    Article  Google Scholar 

  10. Dinh CT, Chen S, Dinh J, Goncalves S, Bas E et al (2017) Effects of intratympanic dexamethasone on high-dose radiation ototoxicity in vivo. Otol Neurotol 38(2):180–186

    Article  Google Scholar 

  11. Seligmann H, Podoshin L, Ben-David J, Fradis M, Goldsher M (1996) Drug-induced tinnitus and other hearing disorders. Drug Saf 14:198–212 (review)

    Article  CAS  Google Scholar 

  12. Taş BM, Simşek G (2017) Cisplatin ototoxicity. KÜ Tıp Fak Derg 19(1):30–36. https://doi.org/10.24938/kutfd.306905

    Article  Google Scholar 

  13. Bokemeyer C, Berger CC, Hartmann JT, Kollmannsberger C, Schmoll HJ et al (1998) Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer. Br J Cancer 77:1355–1362

    Article  CAS  Google Scholar 

  14. Huang E, Teh BS, Strother DR et al (2002) Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys 1(52):599–605

    Article  Google Scholar 

  15. Reavis KM, McMillan GP, Dille MF, Konrad-Martin D (2015) Meta-analysis of distortion product otoacoustic emission retest variability for serial monitoring of cochlear function in adults. Ear Heart 36(5):e251–e260

    Article  Google Scholar 

  16. Martín-Saldaña S, Palao-Suay R, Trinidad A, Aguilar MR, Ramírez-Camacho R et al (2016) Otoprotective properties of 6α-methylprednisolone-loaded nanoparticles against cisplatin: in vitro and in vivo correlation. Nanomedicine 12:965–976

    Article  Google Scholar 

  17. Hargunani CA, Kempton JB, DeGagne JM, Trune DR (2006) Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol 27:564–569

    PubMed  Google Scholar 

  18. Palmer RM, Bridge L, Foxwell NA et al (1992) The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids. Br J Pharmacol 105:11–12

    Article  CAS  Google Scholar 

  19. Kiliç R, Safak MA, Oğuz H, Kargin S, Demirci M et al (2007) Intratympanic methylprednisolone for sudden sensorineural hearing loss. Otol Neurotol 3:312–316

    Google Scholar 

  20. Han X, Yin X, Du X, Sun C (2017) Combined intratympanic and systemic use of steroids as a first-line treatment for sudden sensorineural hearing loss: a meta-analysis of randomized. Control Trials Otol Neurotol 38(4):487–495

    Article  Google Scholar 

  21. Lee JJ, Jang JH, Choo OS, Lim HJ, Choung YH (2017) Steroid intracochlear distribution differs by administration method: systemic versus intratympanic injection. Laryngoscope 128(1):189–194. https://doi.org/10.1002/lary.26562

    Article  CAS  PubMed  Google Scholar 

  22. Hill GW, Morest DK, Parham K (2008) Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections. Otol Neurotol 29(7):1005–1011

    Article  Google Scholar 

  23. Marshak T, Steiner M, Kaminer M, Levy L, Shupak A (2014) Prevention of cisplatin-induced hearing loss by intratympanic dexamethasone: a randomized controlled study. Otolaryngol Head Neck Surg 150(6):983–990

    Article  Google Scholar 

  24. Vidavalur R, Otani H, Singal PK, Maulik N (2006) Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol 11(3):217–225

    CAS  PubMed  PubMed Central  Google Scholar 

  25. García-Alcántara F, Murillo-Cuesta S, Pulido S, Bermúdez-Muñoz JM, Martínez-Vega R et al (2018) The expression of oxidative stress response genes is modulated by a combination of resveratrol and N-acetylcysteine to ameliorate ototoxicity in the rat cochlea. Hear Res 358:10–21. https://doi.org/10.1016/j.heares.2017.12.004

    Article  CAS  PubMed  Google Scholar 

  26. Yan Y, Yang J, Chen G, Mou Y, Zhao Y, Pan L, Ma C, Liu X, Wu C (2011) Protection of resveratrol and its analogues against ethanol-induced oxidative DNA damage in human peripheral lymphocytes. Mutat Res 721(2):171–177

    Article  CAS  Google Scholar 

  27. Avcı D, Erkan M, Sönmez MF, Kökoğlu K, Güneş MS et al (2016) A prospective experimental study on the protective effect of resveratrol against amikacin-induced ototoxicity in rats. J Int Adv Otol 12(3):290–297

    Article  Google Scholar 

  28. Erdem T, Bayindir T, Filiz A, Iraz M, Selimoglu E (2012) The effect of resveratrol on the prevention of cisplatin ototoxicity. Eur Arch Otorhinolaryngol 269(10):2185–2188

    Article  CAS  Google Scholar 

  29. Erkan SO, Tuhanioğlu B, Gürgen SG, Özdaş T, Taştekin B et al (2019) The effect of resveratrol on the histologic characteristics of the cochlea in diabetic rats. Laryngoscope 129(1):E1–E6. https://doi.org/10.1002/lary.27253

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

The authors declare that this article did not receive any financial support during the research and authorship process.

Author information

Authors and Affiliations

  1. Division of Head and Neck Surgery, Department of Otorhinolaryngology, Kırıkkale University School of Medicine, Kirikkale, Turkey

    Gökçe Simsek, Nuray Bayar Muluk, Musa Azman & Rahmi Kılıç

  2. Division of Head and Neck Surgery, Department of Otorhinolaryngology, Kırıkkale Yuksek Ihtısas Hospital, Kirikkale, Turkey

    Burak Mustafa Taş

Authors
  1. Gökçe Simsek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Burak Mustafa Taş
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nuray Bayar Muluk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Musa Azman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rahmi Kılıç
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gökçe Simsek.

Ethics declarations

Conflict of interest

The authors declare that they had no conflict of interest during the preparation and publication of this article.

Ethical approval

This study was carried out with the approval of the ethics of the Experimental Animal Research Center of Kırıkkale University.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Simsek, G., Taş, B.M., Muluk, N.B. et al. Comparison of the protective efficacy between intratympanic dexamethasone and resveratrol treatments against cisplatin-induced ototoxicity: an experimental study. Eur Arch Otorhinolaryngol 276, 3287–3293 (2019). https://doi.org/10.1007/s00405-019-05635-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-019-05635-x

Keywords

Search

Navigation